Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM214A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ATL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HADHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INVS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5S - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASTKD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABGAP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MECR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on